The ANSM is suspending 25 generic drugs marketed in France.
The ANSM is initiating a suspension procedure, as of December 18, of 25 drugs marketed in France. An inspection by the ANSM of a site of the company GVK Bio, which carries out clinical trials including bioequivalence trials in India, has revealed irregularities in documents associated with these trials on which the MA (marketing authorisation) […]
2014 Innovation Award winner signs $25 million development deal with Pfizer
Dear all, We are pleased to announce that one of the 5 finalists of the 2014 Innovation Prize has entered into a $25 million development agreement with pharmaceutical company Pfizer. In fact, Belgian company iTeos Therapeutics, led by Michel Detheux, is developing drug candidates that target Indoleamine-2,3-Dioxygenase (IDO1) and Tryptophan-2,3-Dioxygenase (TDO2). This news highlights the […]
